The Latin America, Middle East and Africa Omics Lab Services Market would witness market growth of 16.8% CAGR during the forecast period (2022-2028).
The expansion of the diagnostic laboratory market is anticipated to be aided by rising demand for inexpensive services, increased awareness of customized medicine, and technological improvements. Another key factor projected to propel the market for omics lab services is the increase in government efforts to offer different amenities, such as reimbursement for diagnostic tests. As part of the integration of many clinical tests, including microbiological testing, several diagnostic labs are collaborating with healthcare organizations.
Genomic testing is often ongoing, similar to genetic treatment, and genomic technology has the potential to provide groundbreaking new medications. Genomic testing is becoming more and more important as the demand for precision treatment grows. The treatment of three babies with X-linked hypohidrotic ectodermal dysplasia recently provided experimental proof of this. In this study, the prenatal intervention was employed to effectively produce a recombinant version of the lacking protein.
Some of the key trends of the Transcriptomics Market are an expansion in the number of biopharmaceutical companies, academic institutions, and research institutes, as well as significant investments in biomarker development and cancer research. Given the vast regions covered by developed-world developments in molecular and omics-based technologies, their adoption and implementation in developed countries remain dubious. Aging and population expansion, as well as increased incidence of risk factors, have made cancer a pervasive problem in African countries.
The Brazil market dominated the LAMEA Omics Lab Services Market by Country in 2021; thereby, achieving a market value of $2.4 billion by 2028. The Argentina market is estimated to grow at a CAGR of 17.4% during (2022 - 2028). Additionally, The UAE market would showcase a CAGR of 16.5% during (2022 - 2028).
Based on Business, the market is segmented into Diagnostic Labs, Research Institutes, and Hospitals. Based on End Use, the market is segmented into Cancer, Pharmaco, Population Studies & Genealogy, Reproductive, Skincare, Nutrition, Vitamin & Supplements, and Forensics & Others. Based on Type, the market is segmented into Proteomics, Transcriptomic, Metabolomics, Genomics, and Epigenetics. Based on Product, the market is segmented into Hardware Equipment, Testing / Lab Services, and Analytics / Interpretation. Based on Frequency of Service, the market is segmented into Continuous, Repeat, and One-off. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Omics Lab Services Market is Predict to reach $139.1 Billion by 2028, at a CAGR of 12.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Agilent Technologies, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Illumina, Inc., BGI Group, Q2 Solutions (IQVIA), Flomics Biotech, PhenoSwitch Bioscience
By Business
By End-Use
By Type
By Product
By Frequency of Service
By Country
Unique Offerings Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
